دورية أكاديمية

Importance of the biochemical investigations for the functional characterization of a NPC1 variant identified by exome sequencing.

التفاصيل البيبلوغرافية
العنوان: Importance of the biochemical investigations for the functional characterization of a NPC1 variant identified by exome sequencing.
المؤلفون: Almenabawy N; Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada., Hung C; Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada., Sosova I; Alberta Newborn Screening and Biochemical Genetics Laboratory, University of Alberta Hospital, Alberta Precision Laboratories, Edmonton, Alberta, Canada.; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada., Mercimek-Andrews S; Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.; Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.; Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
المصدر: American journal of medical genetics. Part A [Am J Med Genet A] 2024 Aug; Vol. 194 (8), pp. e63595. Date of Electronic Publication: 2024 Mar 29.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4833 (Electronic) Linking ISSN: 15524825 NLM ISO Abbreviation: Am J Med Genet A Subsets: MEDLINE
أسماء مطبوعة: Publication: Hoboken, N.J. : Wiley-Blackwell
Original Publication: Hoboken, N.J. : Wiley-Liss, c2003-
مواضيع طبية MeSH: Niemann-Pick C1 Protein*/genetics , Niemann-Pick Disease, Type C*/genetics , Niemann-Pick Disease, Type C*/diagnosis , Niemann-Pick Disease, Type C*/pathology , Exome Sequencing* , Phenotype*, Humans ; Male ; Intracellular Signaling Peptides and Proteins/genetics ; Mutation/genetics ; Infant
مستخلص: Niemann-Pick disease type C (NPC) is one of the lysosomal storage disorders. It is caused by biallelic pathogenic variants in NPC1 or NPC2, which results in a defective cholesterol trafficking inside the late endosome and lysosome. There is a high clinical variability in the age of presentation and the phenotype of this disorder making the diagnosis challenging. Here, we report a patient with an infantile onset global developmental delay, microcephaly and dysmorphic features, homozygous for c.3560C>T (p.A1187V) variant in NPC1. His plasma oxysterol levels were normal on two occasions. His lyso-sphingomyelin-509 (lyso-SM 509) and urinary bile acid levels were normal. Based on the phenotype and biochemical features, the diagnosis of NPC was excluded in this patient. We emphasize the importance of functional characterization in the classification of novel variants to prevent a misdiagnosis. Matching the phenotype and biochemical evidence with the molecular genomic tests is crucial for the confirmation of genetic diagnoses.
(© 2024 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.)
References: Blom, T. S., Linder, M. D., Snow, K., Pihko, H., Hess, M. W., Jokitalo, E., Veckman, V., Syvänen, A. C., & Ikonen, E. (2003). Defective endocytic trafficking of NPC1 and NPC2 underlying infantile Niemann‐Pick type C disease. Human Molecular Genetics, 12(3), 257–272. https://doi.org/10.1093/hmg/ddg025.
Boenzi, S., Catesini, G., Sacchetti, E., Tagliaferri, F., Dionisi‐Vici, C., & Deodato, F. (2021). Comprehensive‐targeted lipidomic analysis in Niemann‐Pick C disease. Molecular Genetics and Metabolism, 134(4), 337–343. https://doi.org/10.1016/j.ymgme.2021.11.005.
Burton, B. K., Ellis, A. G., Orr, B., Chatlani, S., Yoon, K., Shoaff, J. R., & Gallo, D. (2021). Estimating the prevalence of Niemann‐Pick disease type C (NPC) in the United States. Molecular Genetics and Metabolism, 134(1–2), 182–187. https://doi.org/10.1016/j.ymgme.2021.06.011.
Dardis, A., Zampieri, S., Gellera, C., Carrozzo, R., Cattarossi, S., Peruzzo, P., Dariol, R., Sechi, A., Deodato, F., Caccia, C., Verrigni, D., Gasperini, S., Fiumara, A., Fecarotta, S., Carecchio, M., Filosto, M., Santoro, L., Borroni, B., Bordugo, A., … Bembi, B. (2020). Molecular genetics of Niemann–Pick type c disease in Italy: An update on 105 patients and description of 18 NPC1 novel variants. Journal of Clinical Medicine, 9(3), 1–21. https://doi.org/10.3390/jcm9030679.
Deodato, F., Boenzi, S., Taurisano, R., Semeraro, M., Sacchetti, E., Carrozzo, R., & Dionisi‐Vici, C. (2018). The impact of biomarkers analysis in the diagnosis of Niemann‐Pick C disease and acid sphingomyelinase deficiency. Clinica Chimica Acta, 486(July), 387–394. https://doi.org/10.1016/j.cca.2018.08.039.
Fancello, T., Dardis, A., Rosano, C., Tarugi, P., Tappino, B., Zampieri, S., Pinotti, E., Corsolini, F., Fecarotta, S., D'Amico, A., Di Rocco, M., Uziel, G., Calandra, S., Bembi, B., & Filocamo, M. (2009). Molecular analysis of NPC1 and NPC2 gene in 34 Niemann‐Pick C Italian patients: Identification and structural modeling of novel mutations. Neurogenetics, 10(3), 229–239. https://doi.org/10.1007/s10048-009-0175-3.
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., Gauthier, L. D., Brand, H., Solomonson, M., Watts, N. A., Rhodes, D., Singer‐Berk, M., England, E. M., Seaby, E. G., Kosmicki, J. A., … MacArthur, D. G. (2020). The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 581(7809), 434–443. https://doi.org/10.1038/s41586-020-2308-7.
Li, X., Lu, F., Trinh, M. N., Schmiege, P., Seemann, J., Wang, J., & Blobel, G. (2017). 3.3 Å structure of Niemann–Pick C1 protein reveals insights into the function of the C‐terminal luminal domain in cholesterol transport. Proceedings of the National Academy of Sciences of the United States of America, 114(34), 9116–9121. https://doi.org/10.1073/pnas.1711716114.
Maekawa, M., Jinnoh, I., Narita, A., Iida, T., Saigusa, D., Iwahori, A., Nittono, H., Okuyama, T., Eto, Y., Ohno, K., Clayton, P. T., Yamaguchi, H., & Mano, N. (2019). Investigation of diagnostic performance of five urinary cholesterol metabolites for Niemann‐Pick disease type C. Journal of Lipid Research, 60(12), 2074–2081. https://doi.org/10.1194/jlr.M093971.
Monies, D., Abouelhoda, M., Assoum, M., Moghrabi, N., Rafiullah, R., Almontashiri, N., Alowain, M., Alzaidan, H., Alsayed, M., Subhani, S., Cupler, E., Faden, M., Alhashem, A., Qari, A., Chedrawi, A., Aldhalaan, H., Kurdi, W., Khan, S., Rahbeeni, Z., … Alkuraya, F. S. (2019). Lessons learned from large‐scale, first‐tier clinical exome sequencing in a highly consanguineous population. American Journal of Human Genetics, 104(6), 1182–1201. https://doi.org/10.1016/j.ajhg.2019.04.011.
Neßlauer, A. M., Gläser, A., Gräler, M., Engelmann, R., Müller‐Hilke, B., Frank, M., Burstein, C., Rolfs, A., Neidhardt, J., Wree, A., Witt, M., & Bräuer, A. U. (2019). A therapy with miglustat, 2‐hydroxypropyl‐ß‐cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann‐pick disease type C1. Lipids in Health and Disease, 18(1), 1–18. https://doi.org/10.1186/s12944-019-1088-2.
Patterson, M. C., Hendriksz, C. J., Walterfang, M., Sedel, F., Vanier, M. T., & Wijburg, F. (2012). Recommendations for the diagnosis and management of Niemann‐Pick disease type C: An update. Molecular Genetics and Metabolism, 106(3), 330–344. https://doi.org/10.1016/j.ymgme.2012.03.012.
Patterson, M. C., Mengel, E., Vanier, M. T., Moneuse, P., Rosenberg, D., & Pineda, M. (2020). Treatment outcomes following continuous miglustat therapy in patients with Niemann‐Pick disease type C: A final report of the NPC Registry. Orphanet Journal of Rare Diseases, 15(1), 1–10. https://doi.org/10.1186/s13023-020-01363-2.
Reunert, J., Fobker, M., Kannenberg, F., Du Chesne, I., Plate, M., Wellhausen, J., Rust, S., & Marquardt, T. (2016). Rapid diagnosis of 83 patients with Niemann Pick type C disease and related cholesterol transport disorders by Cholestantriol screening. eBioMedicine, 4, 170–175. https://doi.org/10.1016/j.ebiom.2015.12.018.
Schwarz, J. M., Cooper, D. N., Schuelke, M., & Seelow, D. (2014). Mutationtaster2: Mutation prediction for the deep‐sequencing age. Nature Methods, 11(4), 361–362. https://doi.org/10.1038/nmeth.2890.
Vanier, M. T., Gissen, P., Bauer, P., Coll, M. J., Burlina, A., Hendriksz, C. J., Latour, P., Goizet, C., Welford, R. W. D., Marquardt, T., & Kolb, S. A. (2016). Diagnostic tests for Niemann‐Pick disease type C (NP‐C): A critical review. Molecular Genetics and Metabolism, 118(4), 244–254. https://doi.org/10.1016/j.ymgme.2016.06.004.
Vaser, R., Adusumalli, S., Leng, S. N., Sikic, M., & Ng, P. C. (2016). SIFT missense predictions for genomes. Nature Protocols, 11(1), 1–9. https://doi.org/10.1038/nprot.2015.123.
فهرسة مساهمة: Keywords: Niemann–Pick type C; biomarker; developmental delay; exome sequencing; oxysterol
المشرفين على المادة: 0 (Niemann-Pick C1 Protein)
0 (NPC1 protein, human)
0 (Intracellular Signaling Peptides and Proteins)
تواريخ الأحداث: Date Created: 20240329 Date Completed: 20240704 Latest Revision: 20240813
رمز التحديث: 20240813
DOI: 10.1002/ajmg.a.63595
PMID: 38549495
قاعدة البيانات: MEDLINE
الوصف
تدمد:1552-4833
DOI:10.1002/ajmg.a.63595